Bellerophon Therapeutics (NSDQ:BLPH) last week closed an underwritten public offering of 10,000,000 shares of common stock at 70¢ apiece.
The Warren, N.J.-based company also gave underwriters a 45-day option to buy up to an additional 1,500,000 shares of common stock at the same price.
Get the full story at our sister site, Drug Delivery Business News.
The post Bellerophon closes $7m round appeared first on MassDevice.